STOCKSCREENR
Log In

MDLN

NASDAQ

Medline Inc.

$42.16+0.41(+0.98%)Mkt Cap: $34.22B

Key Stats

Market Cap

$34.22B

P/E Ratio

29.48

EPS

$1.43

Dividend Yield

0.00%

52-Week Range

$34.89 — $50.88

Volume

6.56M

Avg Volume

5.64M

Beta

0.00

Valuation

P/E (TTM)

29.48

Forward P/E

28.49

PEG Ratio

-2.60

P/S (TTM)

1.22

P/B (TTM)

3.24

P/FCF

60.32

EV/EBITDA

58.07x

EV/Sales

—

Financial Health

ROE (TTM)

0.08%

ROA (TTM)

0.03%

ROIC

0.02%

Gross Margin

0.25%

Operating Margin

0.08%

Net Margin

0.05%

Debt/Equity

1.17

Current Ratio

4.29

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+4.83%

EPS Growth (5Y)

+4.83%

Sales Growth (3Y)

+0.06%

Sales Growth (5Y)

+0.06%

EPS Est (This Year)

$1.48

EPS Est (Next Year)

$1.29

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

0.00%

Frequency

—

Ex-Dividend Date

—

Cash/Share

$2.39

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$38.00$48.00$55.00
LowMedianHigh

Consensus Target: $47.59(12.9% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

811.42M

Float

816.80M

Free Float %

100.66%

About

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

NASDAQ

IPO Date

2025-12-17

Employees

43000

CEO

James Boyle

Index Membership

—

Website

https://www.medline.com

Medline Inc. (MDLN) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $34.22B, a P/E ratio of 29.48, MDLN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MDLN against other stocks using dozens of fundamental and technical filters.

Similar Stocks

COO

The Cooper Companies, Inc.

$72.05

+1.42%

$14.06B

BDX

Becton, Dickinson and Company

$161.64

+0.85%

$58.56B

ALC

Alcon Inc.

$77.78

-0.01%

$37.91B

RMD

ResMed Inc.

$233.50

+1.25%

$34.08B

WST

West Pharmaceutical Services, Inc.

$239.42

-0.37%

$17.24B

BAX

Baxter International Inc.

$17.62

+3.16%

$9.07B

Frequently Asked Questions

What is Medline Inc.'s P/E ratio?

Medline Inc. (MDLN) has a trailing twelve-month (TTM) P/E ratio of 29.48. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Medline Inc. pay a dividend?

No, Medline Inc. (MDLN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Medline Inc.'s market cap?

Medline Inc. (MDLN) has a market capitalization of $34.22 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about MDLN?

Wall Street analysts have a consensus "Buy" rating on Medline Inc. (MDLN) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $47.59 implies 12.9% upside from the current price.